vimarsana.com

Page 15 - லூபஸ் அடித்தளம் ஆஃப் அமெரிக்கா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Support Notes: Dec 20-26

Support Notes: Dec. 20-26 Times Record Staff Al-Anon: 12 step support groups for families and friends of alcoholics. Info line (479) 441-9705 or (888) 425-2666. • Get A Life Step Study: 12 p.m. Monday at Community Bible Church, 9201 Dallas St., Fort Smith (near playground entrance). Call (479) 806-0184. • Adult Child: 8 p.m. Monday at Midland Heights United Methodist Church, 3500 N. Sixth St., Fort Smith. Call (479) 459-8756. • Steps to Serenity Step Study: 5:30 p.m. Tuesday at Community Bible Church, 9201 Dallas St., Fort Smith (near office entrance). Call (479) 650-2762 or (479) 461-6486. • 4U2: 6 p.m. Tuesday at 426 Holden Street in Booneville. Call (479) 225-9150. • Safe Landing: 6:30 p.m. Tuesday at Trinity United Methodist Church, 1601 E. Shantel Smith Blvd., Muldrow.

Lupus Foundation of America : Sees Big Win with FDA Approval of Benlysta for Lupus Nephritis

Lupus Foundation of America : Sees Big Win with FDA Approval of Benlysta for Lupus Nephritis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Lupus Foundation of America Sees Big Win with FDA Approval of Benlysta for Lupus Nephritis

Lupus Foundation of America Sees Big Win with FDA Approval of Benlysta for Lupus Nephritis News provided by Share this article Share this article WASHINGTON, Dec. 17, 2020 /PRNewswire/ The U.S. Food and Drug Administration (FDA) has approved Benlysta to treat lupus nephritis (lupus-related kidney disease) in adults. The approval is for both the intravenous and subcutaneous formulations. The decision makes Benlysta the first lupus therapy authorized to treat this potentially life-threatening complication of the disease. Up to 60 percent of people with lupus will develop lupus nephritis. Benlysta is a human monoclonal antibody sold by GSK. The FDA first approved Benlysta for lupus in 2011. However, at that time, Benlysta had not been studied for use in individuals with severe lupus nephritis.

POND LEHOCKY GIORDANO: Pond Lehocky Giordano teams up with the Anti-Defamation League for Human Rights Day

By Pond Lehocky Giordano issued the following announcement on Dec. 10. In honor of Human Rights Day, the Pond Lehocky Giordano will donate to the Anti-Defamation League (ADL) as part of the 4th Annual 25 Days of Giving Campaign. This partnership was forged through the firm’s Diversity, Equity, and Inclusion (DEI) Committee.  Once again, the firm be spreading holiday cheer over the next few weeks leading up to the new year by contributing to local and national charities selected by the firm’s clients, partners, attorneys and staff. This is one of many initiatives that the firm sponsors through its charitable arm, Pond Lehocky Community. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.